
PRESS RELEASE
Nyxoah to present at the Oppenheimer 31st Annual Healthcare Conference
Mont-Saint-Guibert, Belgium – 24th February 2021 – Nyxoah SA (Euronext: NYXH) (“Nyxoah” or the “Company”), a health-technology company focused on the development and commercialization of innovative solutions and services to treat Obstructive Sleep Apnea (OSA), today announces the participation of its management team in the Oppenheimer 31st Annual Healthcare Conference on Wednesday, March 17, 2021. Olivier Taelman, CEO of Nyxoah, will represent the Company in a virtual session scheduled to begin at 8:40 AM (ET).
A live webcast of Nyxoah’s session will be available on the Events section of the Company’s investor website at https://investors.nyxoah.com/events or can be accessed via the following link:
Link to webcast
An archived replay of the presentation will be available for 90 days after the conference on Nyxoah’s investor website.
– ENDS –
For further information, please contact:
Nyxoah
Milena Venkova, Corporate Communications Manager
milena.venkova@nyxoah.com
+32 490 11 93 57
About Nyxoah
Nyxoah is a healthtech company focused on the development and commercialization of innovative solutions and services to treat Obstructive Sleep Apnea (OSA)…
From -